Citation 1:
    Title: Biogen : reports fourth quarter and full year 2024 results and provides full year 2025 financial guidance -February 12, 2025 at 08:51 pm | MarketScreener
    URL: https://hk.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-reports-fourth-quarter-and-full-year-2024-results-and-provides-full-year-2025-financial-gui-49035048/#:~:text=Full%20year%202025%20financial%20guidance%3A,25
    Location: chars 235–489

Citation 2:
    Title: SEC Filing | Biogen
    URL: https://investors.biogen.com/node/27926/html#:~:text=Revenue%3A%20%20,2%2C463.0
    Location: chars 535–640

Citation 3:
    Title: Biogen : reports fourth quarter and full year 2024 results and provides full year 2025 financial guidance -February 12, 2025 at 08:51 pm | MarketScreener
    URL: https://hk.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-reports-fourth-quarter-and-full-year-2024-results-and-provides-full-year-2025-financial-gui-49035048/#:~:text=Q4%20%2724%20%20,%7C%20N%2FA
    Location: chars 670–905

Citation 4:
    Title: Biogen : reports fourth quarter and full year 2024 results and provides full year 2025 financial guidance -February 12, 2025 at 08:51 pm | MarketScreener
    URL: https://hk.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-reports-fourth-quarter-and-full-year-2024-results-and-provides-full-year-2025-financial-gui-49035048/#:~:text=continued%20sequential%20growth%20,has%20nearly%20doubled%20the%20number
    Location: chars 1123–1402

Citation 5:
    Title: SEC Filing | Biogen
    URL: https://investors.biogen.com/node/27926/html#:~:text=Revenue%3A%20%20,2%2C463.0
    Location: chars 1403–1508

Citation 6:
    Title: SEC Filing | Biogen
    URL: https://investors.biogen.com/node/27926/html#:~:text=Income%20before%20income%20tax%20,387.9
    Location: chars 1703–1821

Citation 7:
    Title: SEC Filing | Biogen
    URL: https://investors.biogen.com/node/27926/html#:~:text=match%20at%20L516%20Depreciation%20and,75.6
    Location: chars 2029–2151

Citation 8:
    Title: SEC Filing | Biogen
    URL: https://investors.biogen.com/node/28531/html#:~:text=%E2%80%A2For%20the%20third%20quarter%20of,shares%20were%20approximately%20146%20million
    Location: chars 2248–2414

Citation 9:
    Title: SEC Filing | Biogen
    URL: https://investors.biogen.com/node/27926/html#:~:text=Income%20before%20income%20tax%20,387.9
    Location: chars 2453–2571

Citation 10:
    Title: SEC Filing | Biogen
    URL: https://investors.biogen.com/node/28531/html#:~:text=%E2%80%A2Third%20quarter%202024%20net%20cash,capital%20expenditures%2C%20was%20approximately%20%24901%C2%A0million
    Location: chars 2671–2864

Citation 11:
    Title: SEC Filing | Biogen
    URL: https://investors.biogen.com/node/28531/html#:~:text=%E2%80%A2Third%20quarter%202024%20net%20cash,capital%20expenditures%2C%20was%20approximately%20%24901%C2%A0million
    Location: chars 2962–3155

Citation 12:
    Title: SEC Filing | Biogen
    URL: https://investors.biogen.com/node/27926/html#:~:text=Revenue%3A%20%20,2%2C463.0
    Location: chars 3755–3860

Citation 13:
    Title: SEC Filing | Biogen
    URL: https://investors.biogen.com/node/27926/html#:~:text=Income%20before%20income%20tax%20,387.9
    Location: chars 3861–3979

Citation 14:
    Title: Biogen : reports fourth quarter and full year 2024 results and provides full year 2025 financial guidance -February 12, 2025 at 08:51 pm | MarketScreener
    URL: https://hk.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-reports-fourth-quarter-and-full-year-2024-results-and-provides-full-year-2025-financial-gui-49035048/#:~:text=continued%20sequential%20growth%20,has%20nearly%20doubled%20the%20number
    Location: chars 3980–4259

Citation 15:
    Title: Biogen : reports fourth quarter and full year 2024 results and provides full year 2025 financial guidance -February 12, 2025 at 08:51 pm | MarketScreener
    URL: https://hk.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-reports-fourth-quarter-and-full-year-2024-results-and-provides-full-year-2025-financial-gui-49035048/#:~:text=Full%20year%202025%20financial%20guidance%3A,25
    Location: chars 4260–4514

Citation 16:
    Title: SEC Filing | Biogen
    URL: https://investors.biogen.com/node/28531/html#:~:text=%E2%80%A2Third%20quarter%202024%20net%20cash,capital%20expenditures%2C%20was%20approximately%20%24901%C2%A0million
    Location: chars 4548–4741

Citation 17:
    Title: SEC Filing | Biogen
    URL: https://investors.biogen.com/node/28531/html#:~:text=%E2%80%A2For%20the%20third%20quarter%20of,shares%20were%20approximately%20146%20million
    Location: chars 4742–4908

